Mina Golestani
School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iranian Center of Excellence in Health Management, Faculty of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
[ 1 ] - Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran
Abstract Nowadays, bypassing agents such as recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrates (aPCC) are used to treat bleeding episodes in the Hemophilia patients with inhibitors. AryoSeven® is an Iranian biogeneric rFVIIa with homogeneity of efficacy and the nature to NovoSeven in a comparative trial. The current clinical trial aimed to evaluate the cost...
[ 2 ] - Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran
Abstract Nowadays, bypassing agents such as recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrates (aPCC) are used to treat bleeding episodes in the Hemophilia patients with inhibitors. AryoSeven® is an Iranian biogeneric rFVIIa with homogeneity of efficacy and the nature to NovoSeven in a comparative trial. The current clinical trial aimed to evaluate the cost...
[ 3 ] - Cost Components of Treatment Protocols of Haemophilia Patients with Inhibitors using Bypassing Agents in Iran
Bypassing agents are the most commonly used medicines for the treatment of hemophilia patients with inhibitors. The aim of this study is to identify the cost components of management of bleeding vents in hemophilia patients with inhibitors in Iran. This study is a cross-sectional study using a bottom-up approach to determine the cost components of treatment of hemophilia patients with inh...
[ 4 ] - برآورد ارزش آماری جان در بهبود ایمنی جاده‌ای: مطالعه موردی شهر تبریز
همراه با توسعه سریع صنعت حمل و نقل جاده‌ای، بهبود ایمنی و ارزیابی و ارزشگذاری تصادفات، به یک مسئله ضروری در سیاست عمومی تبدیل شده است. در چند دهه گذشته، مطالعات بر پایه برآورد ارزش آماری جان، نقشی بی‌بدیل در برآوردهای هزینه فایده سرمایه‌گذاری در بخش حمل و نقل ایفا کرده است. در این راستا این مطالعه با استفاده از تکنیک انتخاب بیان شده و مدل لاجیت ادغامی، به بررسی تمایل به پرداخت و ارزش آماری جان،...